Publications by the researcher in collaboration with Elvis Teijeira Fernández (19)

2014

  1. Adiponectin and p53 mRNA in epicardial and subcutaneous fat from heart failure patients

    European Journal of Clinical Investigation, Vol. 44, Núm. 1, pp. 29-37

  2. Differential behavior between S100A9 and adiponectin in coronary artery disease. Plasma or epicardial fat

    Life Sciences, Vol. 100, Núm. 2, pp. 147-151

2012

  1. Baseline epicardial adipose tissue adiponectin levels predict cardiovascular outcomes: A long-term follow-up study

    Cytokine, Vol. 60, Núm. 3, pp. 674-680

  2. Changes in lipid transport-involved proteins of epicardial adipose tissue associated with coronary artery disease

    Atherosclerosis, Vol. 224, Núm. 2, pp. 492-499

  3. Coronary artery disease is associated with higher epicardial Retinol-binding protein 4 (RBP4) and lower glucose transporter (GLUT) 4 levels in epicardial and subcutaneous adipose tissue

    Clinical Endocrinology, Vol. 76, Núm. 1, pp. 51-58

  4. Estudios del secretoma y proteoma de grasa epicárdica han determinado niveles de proteínas implicadas en el transporte de lípidos más bajos en pacientes con cardiopatía isquémica

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 8, pp. 106-106

2011

  1. High-resolution two-dimensional gel electrophoresis analysis of atrial tissue proteome reveals down-regulation of fibulin-1 in atrial fibrillation

    International Journal of Cardiology, Vol. 150, Núm. 3, pp. 283-290

  2. Lower epicardial adipose tissue adiponectin in patients with metabolic syndrome

    Cytokine, Vol. 54, Núm. 2, pp. 185-190

  3. Receptor for advanced glycation end-products expression in subcutaneous adipose tissue is related to coronary artery disease

    European Journal of Endocrinology, Vol. 164, Núm. 4, pp. 529-537

  4. Variations in platelet proteins associated with st-elevation myocardial infarction: Novel clues on pathways underlying platelet activation in acute coronary syndromes

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 31, Núm. 12, pp. 2957-2964

2010

  1. Diabetic and nondiabetic patients express similar adipose tissue adiponectin and leptin levels

    International Journal of Obesity, Vol. 34, Núm. 7, pp. 1200-1208

  2. Identificación mediante proteómica de posibles biomarcadores plaquetarios en síndome coronario agudo

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 5, pp. 35-36

  3. Proteins involved in platelet signaling are differentially regulated in acute coronary syndrome: A proteomic study

    PLoS ONE, Vol. 5, Núm. 10

  4. Proteomic analysis of epicardial and subcutaneous adipose tissue reveals differences in proteins involved in oxidative stress

    American Journal of Physiology - Heart and Circulatory Physiology, Vol. 299, Núm. 1

  5. Relationship between epicardial adipose tissue adipocyte size and MCP-1 expression

    Cytokine, Vol. 51, Núm. 2, pp. 207-212

2009

  1. Adipokines as novel cardiovascular disease markers. Pathological and clinical considerations

    Revista Espanola de Cardiologia, Vol. 62, Núm. SUPPL. 2, pp. 9-16

2008

  1. Epicardial adipose tissue expression of adiponectin is lower in patients with hypertension

    Journal of Human Hypertension, Vol. 22, Núm. 12, pp. 856-863

  2. Extension of coronary artery disease is associated with increased IL-6 and decreased adiponectin gene expression in epicardial adipose tissue

    Cytokine, Vol. 43, Núm. 2, pp. 174-180

  3. Why and when do patients with heart failure and normal left ventricular ejection fraction die? Analysis of >600 deaths in a community long-term study

    American Heart Journal, Vol. 156, Núm. 6, pp. 1184-1190